Foundation for Innovative New Diagnostics
The Foundation for Innovative New Diagnostics (FIND) is an international nonprofit established in 2003. Its mission is to enable the development and delivery of diagnostic tests for poverty-related diseases, bridging technology development, policy, and clinical care to reduce barriers to diagnostic innovation and implementation in low- and middle-income countries (LMICs).
Foundation for Innovative New Diagnostics at a glance
In short: Foundation for Innovative New Diagnostics gave $1.4M across 10 grants in 2024 (avg $141K), top state North Carolina. 30% of 2024 grantees were new. Source: 2024 IRS Form 990.
- Annual giving (2024)
- $1,411,110
- -74.4% vs 2023
- Grants made (2024)
- 10
- -50.0% vs 2023
- Average grant
- $141,111
- -48.7% vs 2023
- Median grant
- $40,345
- Total assets
- $51,274,531
- -37.0% vs 2023
- New grantees (estimate)
- 30% first-time grantees (3 of 10, 2024; small sample)
- Primary geography
- North Carolina (36% of itemized 2024 grant dollars)
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated October 2026. New grantees are estimated by matching recipient names across years (methodology).
How to apply to Foundation for Innovative New Diagnostics
- Contact
Phone: (000) 000-0001
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Who Foundation for Innovative New Diagnostics funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
The largest 2024 recipient was University of North Carolina ($506K). Together the top 10 received $1.4M.
Grant Size Distribution
119 grants across all recorded years
The most common grant size was under $50K: 45 grants of 119 (38%).
Geographic Focus
Where this funder awards grants
FIND’s stated mission and programs emphasize diagnostic access and implementation in LMICs. In 2024, grant dollars by recipient state were reported as North Carolina 36%, California 30%, Massachusetts 23%, Illinois 4%, and Indiana 3%. The listed grants also included recipients in Washington and the District of Columbia.
Grant Distribution by State
Share of 2024 grant dollars across all 10 itemized grants.
States
Cities
Is Foundation for Innovative New Diagnostics open to new grantees?
30%
first-time grantees, 2024
In 2024, 3 of 10 grantees (30%) were first-time recipients. With only 10 grantees, that is a small sample: one grantee more or less moves the share by about 10 points. First grants averaged $121K; repeat grants $150K. How we count
Medians: $50K first-time, $40K repeat.
Estimate from itemized grant lists in IRS Form 990 filings (2020–2024). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2024, annual grant giving ranged from $1.4M (2024) to $18.4M (2022). In 2024 it made 10 grants totaling $1.4M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| University of North Carolina Chapel Hill, NC | Laboratory Strengthening to Support Clinical Care and Research | $506,168 |
| Diagnostic Consulting Network Carlsbad, CA | Development of Diagnotic Tests | $410,848 |
| Clinton Health Access Initiative Inc Boston, MA | To Support TB Elimination Efforts | $288,213 |
| American Society of Tropical Med Oakbrook Terrace, IL | Publication of Journal Supplement | $50,000 |
| Quantigen Fisher, IN | Accelerating Tools to Drive Tuberculosis Detection | $40,570 |
| Program appropriate Tech in Health Seattle, WA | Genomics trainings. Supporting the africa cdc workforce development effort for pathogen genomic surveillance | $40,119 |
| Dimagi Inc Cambridge, MA | Production of mobile phone apps that collects data from rapid vitro diagnostic test and that can aid an rdt user in interpreting the test results | $30,457 |
| Georgetown University Center for Global Health Practice and Impact Washington, DC | Driving equitable access to testing in lmics through effective and affordable tests and infrastructure | $24,922 |
| Drugs & Diagnostics for Tropical Diseases San Diego, CA | Rapid Diagnostic Testing for Buruli Ulcer | $10,011 |
| Harvard College Cambridge, MA | Project agreement with harvard for seq&treat mutations catalogue work | $9,802 |
Ready to take the next step with Foundation for Innovative New Diagnostics?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $51,274,531 | $49,306,331 | $56,828,646 | $1,411,110 | 10 | $2,412,155 |
| 2023 | $81,417,302 | $90,612,477 | $96,117,239 | $5,506,497 | 20 | $3,411,063 |
| 2022 | $137,542,319 | $144,248,069 | $146,186,498 | $18,350,776 | 33 | $961,319 |
| 2021 | $189,507,117 | $110,032,140 | $95,593,710 | $12,452,983 | 28 | $624,209 |
| 2020 | $107,298,970 | $98,212,578 | $91,124,840 | $5,080,841 | 28 | $189,810 |
Research compiled by Grantable AI from public sources. Last updated October 2026.
Mission & Focus Areas
FIND states that it enables the development and delivery of needed diagnostic tests for poverty-related diseases and acts as a bridge between experts in technology development, policy, and clinical care. Its 2024 program description covers neglected tropical diseases, medical affairs, women’s health, pandemic threats, and antimicrobial resistance. Examples include work on Chagas disease and sleeping sickness diagnostics, HPV testing and cervical cancer screening, outbreak-disease test directories and evaluations, and antimicrobial-resistance diagnostic capacity.
The 2024 grants show support for laboratory strengthening, diagnostic-test development, tuberculosis detection and elimination, genomics training, mobile applications for rapid-test data, equitable access to testing in LMICs, and rapid testing for Buruli ulcer. Grantees’ own descriptions include the Clinton Health Access Initiative’s work to strengthen and sustain health systems in LMICs, PATH’s work to improve healthcare and develop affordable health products, and research and education at Georgetown University and Harvard.
Grantmaking
In filing year 2024, FIND reported 10 grants totaling $1,411,110. Grants ranged from $9,802 to $506,168, with a median of $40,344. The largest awards listed were $506,168 to the University of North Carolina for laboratory strengthening to support clinical care and research; $410,848 to Diagnostic Consulting Network for diagnostic-test development; and $288,213 to the Clinton Health Access Initiative for tuberculosis elimination efforts. Other listed recipients included the American Society of Tropical Medicine, Quantigen, PATH, DiMagi, Georgetown University, Drugs & Diagnostics for Tropical Diseases, and Harvard College.
FIND’s calls-for-partners page lists no open calls and includes a closed-calls archive. Its website describes industry partnerships to advance diagnostic testing and an expression-of-interest call for developers of molecular true point-of-care devices for outbreak diseases. The expression-of-interest document is dated November 2024 and is a past cycle.
Leadership & Key People
Leadership team and compensation from IRS filings
The 2024 filing lists Ayoade Alakija as chair of the board. Board members listed include David Heymann, Christian Frutiger, Shobana Kamineni, Marcel Tanner, Michele Costaforlaz, Precious Matsoso, Rick Arthur Bright (through August 2024), and Soumya Swaminathan (through August 2024). Cassandra Kelly-Cirino is listed as vice president of health programmes through August 2024.
Foundation for Innovative New Diagnostics is led by William Rodriguez, Chief Executive Officer on every filing since 2022; 17 of 26 officers listed in 2024 are compensated.
Officers on the 2024 filing
William Rodriguez
Chief Executive Officer
On filings since 2022
40 hrs/week
$324K (2022) → $198K (2024)
Dayo Adetifa
Chief Transformation Officer & CEO
New on the 2024 filing
40 hrs/week
$139K (2024)
Ayoade Alakija
Chairman of the Board
On filings since 2023
1 hr/week
No compensation reported
Beatrice Mouton
Director & Human Resources
Head of Human Resources → Director & Human Resources, 2021
On filings since 2020
40 hrs/week
$187K (2020) → $261K (2024)
Louisa Chaubert
Director of Finance
Director of Finance → Vice President Finance, 2021
Vice President Finance → Director of Finance, 2022
On filings since 2020
$246K (2020) → $96K (2024)
Morten Ruhwald
Director & Tuberculosis Programme
Head of Tuberculosis → Director & Tb Programme, 2021
Director & Tb Programme → Director & Tuberculosis Programme, 2023
On filings since 2020
40 hrs/week
$201K (2020) → $245K (2024)
Sharon Saacks
Senior Director & Programme Operations
Director of Operations → Senior Director & Programme Operations, 2023
On filings since 2020
40 hrs/week
$212K (2020) → $231K (2024)
Brooke Nichols
Senior Director & Impact
On filings since 2023
40 hrs/week
$254K (2023) → $265K (2024)
Kevin Tetteh
Director & Malaria Fever Programme
New on the 2024 filing
40 hrs/week
$182K (2024)
Maria Cecilia Ferreyra Arellano
Director of Amr Programme
New on the 2024 filing
40 hrs/week
$213K (2024)
Shaukhat Ali Khan
Director Strategic Information
New on the 2024 filing
40 hrs/week
$235K (2024)
Sergio Carmona
Chief Medical Officer
Chief Access Officer → Chief Medical Officer, 2021
On filings since 2020
40 hrs/week
$261K (2020) → $284K (2024)
Marta Fernandez Suarez
Chief Technology Officer
On filings since 2021
40 hrs/week
$263K (2021) → $286K (2024)
Sanjay Sarin
Vice President & Access
Vice President Access → Vice President & Access, 2022
On filings since 2021
40 hrs/week
$212K (2021) → $232K (2024)
Cassandra Kelly-Cirino
Vice President & Health Programmes
On filings since 2023
40 hrs/week
$267K (2023) → $191K (2024)
Norma Torres
Chief Operating Officer
On filings since 2023
40 hrs/week
$145K (2023) → $216K (2024)
Willo Brock
Executive Vice President & External Affairs
On filings since 2023
40 hrs/week
$321K (2023) → $164K (2024)
Darryl English
Deputy Director & Finance
New on the 2024 filing
40 hrs/week
$343K (2024)
David Heymann
Member of the Board
Board Member → Member of the Board, 2021
On filings since 2020
1 hr/week
No compensation reported
Kamineni Shobana
Member of the Board
Board Member → Member of the Board, 2021
On filings since 2020
1 hr/week
No compensation reported
Marcel Tanner
Member of the Board
Board Member → Member of the Board, 2021
On filings since 2020
1 hr/week
No compensation reported
Frutiger Christian
Member of the Board
Board Member → Member of the Board, 2023
On filings since 2021
1 hr/week
No compensation reported
Michele Costaforlaz
Member of the Board
On filings since 2023
1 hr/week
No compensation reported
Precious Matsoso
Member of the Board
On filings since 2023
1 hr/week
No compensation reported
Rick Arthur Bright
Member of the Board
On filings since 2023
1 hr/week
No compensation reported
Soumya Swaminathan
Member of the Board
On filings since 2023
1 hr/week
No compensation reported
Former officers (32)
- Former: Carlos Morel Medicis (2020–2023) — Member of the Board
- Former: Daniel Robert Camus (2020–2023) — Member of the Board
- Former: Iona Kickbush (2020–2023) — Member of the Board
- Former: Stefano Ongarello (2020–2023) — Director & Data Science
- Former: Sylvain Bieler (2020–2023) — Principal Scientist
- Former: Emma Jane Hannay (2021–2023) — Chief Access Officer
- Former: Daniel Bausch (2022–2023) — Snr. Advisor CEO & Global Health Secretary
- Former: Andrew John Jack (2020–2022) — Member of the Board · Filing note: Ended 11/2022
- Former: Gao Fu (2020–2022) — Member of the Board · Filing note: Ended 922
- Former: Mark Kessel (2020–2022) — Chairman of the Board · Filing note: Ended 11/2022
- Former: Michael Watson (2020–2022) — Member of the Board · Filing note: Ended 922
- Former: Sheila Tlou (2020–2022) — Member of the Board · Filing note: Ended 922
- Former: Willo Brock start (2021–2022) — Vice President & External Affairs
- Former: Aditi Srinivasan (2022) — Director & Data Science
- Former: Ayoade Alakija start (2022) — Chairman of the Board
- Former: Cassandra Kelly-Cirinostart922 (2022) — Vice President & Health Programmes
- Former: Precious Matsoso start (2022) — Member of the Board
- Former: Soumya Swaminathanstart1122 (2022) — Member of the Board
- Former: Catharina Boehme (2020–2021) — Chief Executive Officer · Filing note: Ended 221
- Former: Rangarajan Sampath (2020–2021) — Chief Scientific Officer · Filing note: Ended 121
- Former: Sarah-Jane Loveday (2020–2021) — Director & Communications
- Former: William Rodriguez START (2021) — Chief Executive Officer
- Former: Anita Suresh (2020) — Head of Sequencing
- Former: Cassandra Kelly (2020) — Director of Emerging Threat
- Former: Elena Ivanova (2020) — Tech. Innovation Lead
- Former: Hiedi Albert (2020) — Head of South Africa Find
- Former: Jon Bastow (2020) — Director of Business Development & Resour
- Former: Joseph Ndung'u (2020) — Head Ntd Program & Find Kenya
- Former: Pamela Nabeta (2020) — Senior Manager Qual & Med Affair
- Former: Sabine Dittrich (2020) — Head of Malaria & Fever
- Former: Sonjelle Shilton (2020) — Hepatitis Lead
- Former: Zachary Benjamin Katz (2020) — Chief Access Officer
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $343K, to Darryl English (Deputy Director, Finance (Thru 11/24)). 17 officers or directors reported compensation on that filing.
Frequently asked questions about Foundation for Innovative New Diagnostics
How much does Foundation for Innovative New Diagnostics give each year?
Foundation for Innovative New Diagnostics gave $1.4M across 10 grants in 2024, according to its 2024 IRS Form 990. In 2023 it gave $5.5M across 20 grants.
What is Foundation for Innovative New Diagnostics's typical grant size?
Foundation for Innovative New Diagnostics's median grant in 2024 was $40,345, and its average grant was $141,111, across 10 grants on its 2024 IRS Form 990. Organizations receiving their first grant from Foundation for Innovative New Diagnostics that year got $121K on average.
Where does Foundation for Innovative New Diagnostics give grants?
Foundation for Innovative New Diagnostics's top state is North Carolina, with 36% of the grant dollars itemized on its 2024 IRS Form 990. The next largest states were California (30%) and Massachusetts (23%). The most frequent recipient cities were Cambridge, MA (2 grants).
Does Foundation for Innovative New Diagnostics give general operating support?
Not in 2024: none of the 10 grants with a stated purpose on Foundation for Innovative New Diagnostics's 2024 IRS Form 990 were described as general or operating support.
Who are Foundation for Innovative New Diagnostics's largest grantees?
Foundation for Innovative New Diagnostics's largest 2024 grantees include University of North Carolina ($506,168), Diagnostic Consulting Network ($410,848) and Clinton Health Access Initiative Inc ($288,213), according to its 2024 IRS Form 990. Together they received 85% of its itemized 2024 grant dollars.
How large is Foundation for Innovative New Diagnostics?
Foundation for Innovative New Diagnostics reported $51.3M in total assets on its 2024 IRS Form 990. Its revenue that year was $49.3M.
What does Foundation for Innovative New Diagnostics fund?
FIND states that it enables the development and delivery of needed diagnostic tests for poverty-related diseases and acts as a bridge between experts in technology development, policy, and clinical care. See mission & focus areas ↑
How do I apply for a grant from Foundation for Innovative New Diagnostics?
Foundation for Innovative New Diagnostics has no public application process in the sources Grantable reviewed. Contact the foundation directly before submitting a request.
What is Foundation for Innovative New Diagnostics's EIN?
Foundation for Innovative New Diagnostics's EIN (Employer Identification Number) is 98-0407553. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated October 2026. Sourced from IRS Form 990 filings. Research dossier generated October 2026.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS November 15, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS November 15, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS November 15, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS November 15, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS November 17, 2025)
- IRS filings on file for fiscal years 2020–2024
Live grants for the work Foundation for Innovative New Diagnostics funds
Medical Research Open opportunities, soonest deadline first.
Explore Open Grants
Browse active grant opportunities in Foundation for Innovative New Diagnostics's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
American Lung Association
Chicago, IL
The American Lung Association funds research on lung disease, lung cancer, tobacco use, and air quality, primarily through defined research-award programs for investigators at eligible U.S. nonprofit institutions. Recent grants ranged from $25,000 to $825,000, with a median of about $201,000; applications are submitted through specified award mechanisms, and the profile does not state whether unsolicited requests are accepted.
Assets
$225.7M
Grants
51
Total Given
$13.5M
Alexs Lemonade Stand Foundation
Wynnewood, PA
Alex’s Lemonade Stand Foundation primarily funds pediatric cancer research, including early-stage science and clinical trials, with additional programs supporting affected families and raising awareness. Its 2025 grants ranged from $6,000 to $2.3 million, with a median of about $162,000, and supported institutions in the United States, Canada, and Europe; the profile does not state whether it accepts unsolicited requests.
Assets
$40.6M
Grants
58
Total Given
$19.1M
The Susan G Komen Breast Cancer Foundation Inc
Dallas, TX
The Susan G. Komen Breast Cancer Foundation funds breast cancer research and programs supporting education, patient navigation, financial assistance, and access to care. Its 2025 grants ranged from $2,681 to $945,992, with a median of $158,660, and it funds work in the United States and 24 other countries. Research applications require an LOI, and full applications are by invitation; whether it accepts unsolicited requests is not stated.
Assets
$178.9M
Grants
61
Total Given
$16.1M
Bristol-Myers Squibb Foundation Inc
Princeton, NJ
The Bristol-Myers Squibb Foundation supports health access and stronger health systems, with a focus on adult and pediatric cancers, blood disorders, brain health, and clinical-trial participation in the United States, Brazil, India, and ten Sub-Saharan African countries. In 2024, its median grant was about $134,000, though awards varied widely; it does not state whether it accepts unsolicited requests, and advises prospective applicants to contact the Foundation about its process.
Assets
$83.3M
Grants
144
Total Given
$67.7M
Rheumatology Research Foundation
Atlanta, GA
The Rheumatology Research Foundation funds research, career development, education, and training to improve health for people with rheumatic diseases, supporting applicants from early study through established careers. In 2025, its 170 grants ranged from $500 to $400,000, with a median of $50,000, and went to recipients across multiple U.S. states. Applications are submitted online through individual award programs; whether unsolicited requests are accepted is not stated.
Assets
$76.4M
Grants
170
Total Given
$11.6M
The George Washington University
Ashburn, VA
The George Washington University’s reported grants are primarily subaw awards supporting education, scholarly research, research support, and community-engaged scholarship, with recipients including universities, research organizations, and community organizations. In 2025, grants ranged from $5,000 to $3.42 million, with a median of about $131,000; Nashman Faculty Development awards are generally $2,000–$5,000. Funding went mainly to recipients in Washington, D.C., and several other states, and the profile does not state whether unsolicited requests are accepted.
Assets
$5.5B
Grants
191
Total Given
$54.1M
More similar funders
Cite this profile
Grantable. (2026). Foundation for Innovative New Diagnostics funder profile. GrantGraph. Retrieved October 17, 2026, from https://grantable.co/funders/foundation-for-innovative-new-diagnostics-morg_14c8a84837444e0797c0c05908abd70b
BibTeX
@misc{grantable_980407553_2026,
author = {{Grantable}},
title = {{Foundation for Innovative New Diagnostics funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/foundation-for-innovative-new-diagnostics-morg_14c8a84837444e0797c0c05908abd70b},
note = {Accessed 2026-10-17. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from Foundation for Innovative New Diagnostics's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Foundation for Innovative New Diagnostics down — hundreds of funders to go?